TES Pharma and École Polytechnique Fédérale de Lausanne (EPFL) Announce R&D Collaboration on Small Molecule Therapies for Metabolic Disorders and Age-Related Diseases

PERUGIA, Italy and LAUSANNE, Switzerland, July 2, 2015 /CNW/ – TES Pharma and EPFL announce a new research and development collaboration on novel small molecule modulators of the kynurenine pathway as therapies for metabolic disorders and age-related diseases. (Logo: http://photos.prnewswire.com/prnh/20150625/225612LOGO ) The collaboration brings together TES Pharma, a research-based biotech company led by Professor Roberto …

Advertisements